Budget Impact Models

Budget Impact Models

The RXA Budget Impact Model enables pharmaceutical companies to use the NHS’s own data to produce realistic and plausible cost saving prescribing switch strategies.

With the RXA Budget Impact model you can:

  • Create summary overviews at annual and portfolio levels
  • Drill down to underlying detailed product-specific calculations
  • Use tables, charts and maps in the purpose-built dashboard to provide extensive, highly visual and easy to interpret analytics
  • Make on the spot adjustments of model parameters – (E.g. switch %) via slider controls
  • Automatically rank the top ‘X’ GP practices to target
  • Create outputs to leave behind after meetings – Including CCG or GP practice level branded reports containing details of identified cost savings
We make analytics simple
Request your demonstration today

“At a CCG level we can show our customers how we can work with individual surgeries to get substantial cost savings and utilize their budgets better. We work with medicines management teams to help them to save money whilst also improving outcomes.”

Country Manager UK, Leading Diagnostics Company

“RX Analyser is an extremely intuitive tool with numerous beneficial features.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“The feature I like most? The ability to drill down to competitor sales.”

Senior Manager, Global Healthcare Company, 2016

“One of the simplest dashboards I have used, this product is very flexible. We use it extensively to gain insight into our business, down to a CCG level.”

National Sales Manager, Leading Pharmaceutical Company, 2016

“We chose Rx Analyser is because we wanted visibility of sales for our products. Rx Analyser is perfect for delivering a detailed level of data to practice level. The data is enabling us to set targets at territory level and assist our planning process as we can understand our competitor sales via Rx Analyser far better than previously.”

National Paediatric Manager, UK Health and Wellness Company

“The budget impact models are a real benefit.”

National Sales Manager, UK Pharmaceutical Company

Sign up for added insights